MedPath

Collaborative care program for patients with treatment resistant schizophrenia.

Completed
Conditions
long-lasting psychosis
treatment resistant schizophrenia
10039628
Registration Number
NL-OMON52870
Lead Sponsor
Reinier van Arkelgroep (Den Bosch)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
3
Inclusion Criteria

The intervention study includes patients over 18 years of age with treatment
resistant schizophrenia and who receive treatment from participating EPIT and
FACT (these patients were identified in the cross-sectional study). These
patients do not use clozapine at the time of inclusion.

Exclusion Criteria

- Patients who not master the Dutch language to complete in questionnaires and
giving an interview.
- Patients without informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Improving social functioning</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Reduce psychotic symptoms<br /><br>Improve quality of life<br /><br>Improve recovery<br /><br>Improve shared decision making<br /><br>Enhance self management<br /><br>Reduce and/or early identifcation of somatic co-morbidit</p><br>
© Copyright 2025. All Rights Reserved by MedPath